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Abstract To assess the role of orexin receptor signaling in
neuron-like cells, Neuro-2a murine neuroblastoma and PC12
human pheochromocytoma cells were stably transfected with
human OX1 or OX2 receptors. Activation of both receptors
strongly elevated cellular inositol phosphates and Ca2+. A di¡er-
ence in the potency between orexin-A and -B was seen for OX1,
but not OX2 receptors. Dependence of the orexin-mediated
Ca2+ response on extracellular Ca2+ and the observed Ba2+
in£ux indicate that in addition to phospholipase C, orexin re-
ceptors also may couple to similar non-voltage-gated Ca2+
channels in neuronal cells as previously characterized in non-
neuronal cells. * 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The recently discovered neuropeptides orexin-A and orexin-
B mediate their e¡ects through two G-protein-coupled recep-
tors named OX1 and OX2 receptors [1]. In the brain, orexins
are thought to regulate sleep, feeding and autonomic func-
tions, and similar functions may be mediated even in the
periphery (reviewed in [2]). Little is known about the cellular
e¡ects of orexins. In neuronal slice preparations from the
areas where orexinergic neurons terminate, the main response
to application of orexins is an increase in synaptic activity (see
e.g. [3]). Both presynaptic and postsynaptic e¡ects have been
shown (see e.g. [4]), but the mechanisms for these e¡ects are
rather unclear and the investigations are made di⁄cult by
methodological problems associated with the use of brain
preparations. In neurons, orexins also cause Ca2þ elevations
[5,6]. The pharmacological characteristics of orexin receptor
responses have been determined so far only using recombi-
nantly expressed receptors in Chinese hamster ovary (CHO)
cells. In these cells, both orexin receptors have been shown to
induce Ca2þ elevation [1], which to some degree is dependent
on receptor-activated Ca2þ channels [7]. To avoid the prob-
lems associated with isolation of neuronal cells and the non-
neuronal characteristics of CHO cells, we have in this study
chosen to establish homogeneous model systems for orexiner-
gic signaling in neuronal settings by transfection of two often
used neuron-like model cell lines PC12 (human pheochromo-
cytoma) and Neuro-2a (murine neuroblastoma).
2. Materials and methods
2.1. Chemicals
Dextrometorphane, EGTA (ethylene glycol bis(L-aminoethyl ether)-
N,N,NP,NP-tetraacetic acid), nifedipine and probenecid (p-(dipropyl-
sulfamoyl)benzoic acid) were purchased from Sigma (St. Louis, MO,
USA) and thapsigargin, g-conotoxin GVIA and MVIIC and g-aga-
toxin IVA from RBI (Natick, MA, USA). Fura-2 acetoxymethyl ester
was purchased from Molecular Probes Inc. (Eugene, OR, USA) and
human orexin-A and -B from Neosystem (Strasbourg, France). Dig-
itonin was purchased from Merck AG (Darmstadt, Germany) and
myo-[2-3H]inositol (1 mCi/ml) from Amersham Pharmacia Biotech
(Buckinghamshire, UK).
2.2. Cell culture and transfection
PC12 and Neuro-2a cells were grown continuously in Dulbecco’s
modi¢ed Eagle’s medium (Life Technologies Inc., Paisley, UK) sup-
plemented with 100 U/ml penicillin G (Sigma), 80 U/ml streptomycin
(Sigma) and 10% (v/v) fetal calf serum (Life Technologies). The
cDNA for human orexin receptor subtypes was cloned into the
pCDNA 3.1 vector containing resistance for neomycin. These vectors
were used together with the transfection reagents Fugene (Roche,
Basel, Switzerland; PC12 cells) and Lipofectamine (Life Technolo-
gies; Neuro-2a cells). Forty-eight hours after transfection 800 Wg/ml
geneticin (Life Technologies) was added to the medium for selection
and the cells then were cultured for 3 weeks to obtain stable pan-
clones. Pan-clones of PC12 cells were diluted and plated on culture
dishes and the expanded single-cell-based colonies were used for cre-
ation of clonal cell lines (see Section 3). The stable clonal cell lines
were cultured in the presence of 500 Wg/ml geneticin.
2.3. Intracellular Ca2+ measurements using Ca2+ imaging
The coverslips with Neuro-2a or PC12 cells were loaded with fura-2
acetoxymethyl ester (4 WM, 20 min, 37‡C) in TES-bu¡ered medium
(TBM, consisting of 137 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1.2 mM
MgCl2, 0.44 mM KH2PO4, 4.2 mM NaHCO3, 10 mM glucose, and
20 mM TES (N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic
acid) adjusted to pH 7.4 with NaOH). The measurements were per-
formed as described in [8]. The additions in the chamber were made
by perfusion.
2.4. Intracellular Ca2+ and inositol phosphate measurements in
suspensions of cells
The experiments were performed as described previously [7]. For
Ca2þ measurements, the cells were harvested and loaded with fura-2
acetoxymethyl ester. The measurements were performed in TBM con-
taining 1 mM probenecid at 37‡C using Hitachi F-2000 and F-4000
£uorescence spectrophotometers. Experiments were calibrated by add-
ing 60 Wg/ml digitonin (for the maximum £uorescence) and 10 mM
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EGTA (for the minimum £uorescence). For inositol phosphate mea-
surements, the cells were loaded with 3 WCi/ml myo-[3H]inositol for
20 h in the culture medium. The cells were stimulated with the ago-
nists for 20 min in the presence of 10 mM LiCl and the reactions
terminated by spinning and replacement of the bu¡er with ice-cold
perchloric acid. The total inositol phosphate fraction of the neutral-
ized supernatants was isolated with anion exchange chromatography.
Non-linear curve-¢tting of the data was performed using SigmaPlot
for Windows 4.01 (Jandel Scienti¢c, Corte Madera, CA, USA).
3. Results
The stable pan-clones of OX1 and OX2 receptor-transfected
Neuro-2a cells were examined using fura-2 Ca2þ imaging. This
approach was chosen instead of receptor binding since the
Ca2þ imaging allows examination of individual cells. In Neu-
ro-2a pan-clones expressing any of the orexin receptors, all the
cells responded to stimulation with orexin-A, and further ex-
periments were thus performed with these. Orexin-A and
-B stimulated inositol phosphate production in Neuro-2a cells
expressing orexin receptors in a concentration-dependent
manner (Fig. 1A,B). The EC50 values for orexin-A and -B
acting at the OX1 receptor were 2.9 S 1.8 and 52S 20 nM,
respectively, and at the OX2 receptor 1.9 S 1.1 and 2.2S 0.9
nM, respectively. The maximum response to stimulation with
either orexin was approximately eight times the basal level in
either cell line whereas endogenous P2Y purinoceptor [9] stim-
ulation with ATP only elevated inositol phosphate levels
2^2.5-fold.
Concentration^response relationship for the orexin-elicited
Ca2þ elevation was measured in cell suspension to obtain sta-
tistically more representative values. The concentration^re-
sponse relationships were very similar to those obtained in
inositol phosphate measurements (Fig. 1C,D). The EC50 val-
ues for orexin-A and -B acting at the OX1 receptor were
1.9 S 1.3 and 19S 2 nM, respectively, and at the OX2 receptor
1.0 S 0.3 and 1.0S 0.3 nM, respectively. Upon reduction of
extracellular Ca2þ (Ca2þe ) to 140 nM, the EC50 values were
shifted one to three orders of magnitude to the right, which is
in agreement with previous results from CHO cells [7].
Depolarization of Neuro-2a cells with 65 mM Kþ did not
lead to any Ca2þ elevation, and the Ca2þ response to subse-
quent addition of orexins was not a¡ected (data not shown).
The Ca2þ responses were also insensitive to various inhibitors
of voltage-gated Ca2þ channels (VGCC) such as nifedipine
(10 WM), g-conotoxin GVIA and MVIIC (2 WM), g-agatoxin
IVA (200 nM) and dextrometorphane (100 WM) (data not
shown).
In the PC12 cell pan-clones, only 10% of cells responded to
orexin-A with a Ca2þ elevation. Single-cell-based clones of
transfected PC12 cells were therefore isolated. In the identi¢ed
orexin receptor-positive clonal cell lines, all the cells re-
sponded to orexin-A (Fig. 2A). The same pattern of inositol
phosphate response as with Neuro-2a cells was seen with
PC12 cells. Thus orexin-A was 30-fold (EC50 = 5.6 S 3.3 nM)
more potent than orexin-B (EC50 = 100S13 nM) at the OX1
receptor whereas both orexins were equipotent at the OX2
receptor (EC50 = 39S 5 and 41S12 nM, respectively) (Fig.
2B,C). The maximum response to orexins varied in di¡erent
Fig. 1. Concentration^response relationships for orexin-A and -B at the OX1 (A, C) and OX2 receptors (B, D) in Neuro-2a cells with respect
to the inositol phosphate mobilization (IP; A, B) and Ca2þ elevation (Ca2þ ; C, D). Ca2þ responses are shown both in the presence of normal
and low Ca2þe . All measurements were performed in triplicate with at least three di¡erent batches of cells ; the error bars indicate standard error
of the mean.
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cell lines, but the altogether highest responses (Weight times
the basal) were much higher than those elicited by endogenous
P2Y purinoceptor stimulation with ATP (W2^2.5 times the
basal). Ca2þ imaging experiments indicated that the concen-
tration^response curve for orexins was similarly shifted in
PC12 cells as in Neuro-2a upon reduction of Ca2þe (data not
shown). To judge whether this Ca2þe sensitivity was caused by
Ca2þ-dependent binding of orexins to their receptors or by the
dependence of the response on Ca2þ in£ux, we also performed
experiments where Ca2þe was replaced with Ba
2þ. Mere remov-
al of Ca2þ abolished the response to low concentrations of
orexins, but upon addition of Ba2þ a rapid and stable increase
in the 340 nm £uorescence was seen. This increase, not present
in the absence of orexins, is indicative of Ba2þ in£ux (data not
shown).
As a control, non-transfected PC12 and Neuro-2a cells were
exposed to orexins. No Ca2þ or inositol phosphate response
was observed.
4. Discussion
Previous studies on coupling of orexin receptors to Ca2þ
elevation are based on expression of these receptors in CHO
cells [1,7,10] or recordings from isolated neurons [5,6]. In this
study, we have stably expressed OX1 and OX2 orexin recep-
tors in two neuron-like cell lines in order to investigate the
function of these receptors in neuronal settings. In these cell
lines, Neuro-2a and PC12 cells, we can con¢rm the result
from rat neurons [5,6] and from non-neuronal CHO cells
[7,11], which show that orexins produce Ca2þ elevations
mainly in an Ca2þe -dependent manner. For the ¢rst time, we
can also show that both orexin receptors, when activated by
either of the endogenous orexin peptides, mobilize cellular
inositol phosphates.
In rat neurons, orexin-stimulated Ca2þ in£ux has been sug-
gested to relate to activation of VGCC [5,6]. In contrast, we
have previously shown that OX1 receptors connect to non-
VGCC in CHO cells [7]. In this study we found no evidence
for the involvement of VGCC, yet the Ca2þ and inositol phos-
phate responses were dependent on the Ca2þe . This is phenom-
enologically similar to CHO cells, where at low orexin-A con-
centrations Ca2þ in£ux is the primary response, but it can
amplify phospholipase C (PLC) so that also Ca2þ release
and IP3 production are obtained. At 100-fold higher concen-
trations, orexin-A activates Ca2þ release even in the absence
of Ca2þe [7]. It remains to be shown what lies behind the Ca
2þ
e -
dependence of orexin responses in Neuro-2a and PC12 cells.
Our experiments with Ba2þ in£ux yet suggest ^ similarly to
CHO cells ^ that this is due to Ca2þ in£ux and not to Ca2þ-
dependence of orexin binding. Increased Ca2þ in£ux as an
ubiquitous mechanism for orexinergic signaling could explain
the increased transmitter release suggested as one of the mech-
anisms behind the orexin receptor-mediated increase in syn-
aptic activity. Orexin-stimulated noradrenaline release from
rat cerebral cortex shows a similar shift in the concentra-
tion^response curves upon removal of Ca2þe [12].
How orexin receptors regulate intracellular signaling path-
ways has not yet been clari¢ed. OX2 receptors have been
shown to be able to activate members of the Gi, Gs and Gq
G-protein families [13]. Though coupling to Ca2þ elevation
has been shown in di¡erent systems, the relationship of this
to PLC activation is unclear. The results of the present study
show a strong coupling of orexin receptors to inositol phos-
phate mobilization, suggesting that PLC is one of the central
e¡ectors for orexin receptors even in neuronal cells. PLC-
mediated protein kinase C activation might thus explain
some of the depolarizing e¡ects of orexins.
Pharmacological characterization of orexin receptors has
been performed in CHO cells. There, orexin-A activates
OX1 receptors up to 10^100 times more potently than orex-
in-B but both peptides are equipotent at the OX2 receptors
[1,10]. It has been di⁄cult to ¢nd unequivocal support for this
selectivity in tissues since usually both receptor subtypes are
expressed. Therefore, the results of the present study are im-
portant in showing that these pharmacological pro¢les hold
true for the responses measured even in neuronal settings.
In conclusion, the results presented here indicate that acti-
vation of PLC and Ca2þ elevation are central for orexin sig-
naling in neuron-like cells. Analysis of the pharmacological
pro¢le of orexins shows that orexin receptors behave similarly
in neuron-like cells as in CHO cells. The results based on the
Ca2þe -dependence of the Ca
2þ responses suggest that Ca2þ-
Fig. 2. In A, Ca2þ responses to stimulation with 100 nM orexin-A in a single-cell-based clonal cell line (PC12-hOX1-H1). The data are from
one coverslip. Each trace indicates an individual cell as measured using Ca2þ imaging. In B and C, concentration^response relationships for
orexin-A and -B at the OX1 (B) and OX2 receptors (C) in PC12 cells with respect to the inositol phosphate mobilization. All measurements
were performed in triplicate with at least three di¡erent batches of cells; the error bars indicate standard error of the mean.
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permeable cation channels may be activated by orexin recep-
tors, though further experiments are required to con¢rm
this.
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